Amethyst and Stingray form Europe’s Largest oncology platform
Pan-European mid-market investment firm Fremman Capital has acquired Stingray Healthcare from Jacobs Capital to merge it with Amethyst Healthcare, creating Europe’s largest independent cancer care platform . The transaction unites two complementary oncology networks with a shared mission to expand access to high-quality, patient-centred radiotherapy services across Western and Central Europe. The merger leverages Amethyst’s established footprint in France, Poland,…
Amethyst Healthcare acquires Portuguese radiotherapy group Júlio Teixeira
Amethyst Healthcare has acquired Júlio Teixeira, a well-established provider of radiotherapy services operating in Porto and Braga. This acquisition forms part of its strategic expansion in Western Europe and will strengthen the group’s capacity to deliver advanced radiotherapy care in Portugal. Announced on October 6, 2025, the deal represents a significant strategic milestone in Amethyst’s expansion across Western Europe and…